You have free access to this content

Hepatology

Cover image for Vol. 57 Issue 3

March 2013

Volume 57, Issue 3

Pages 857–1289

  1. Master's Perspective

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      LiverTox: A website on drug-induced liver injury (pages 873–874)

      Jay H. Hoofnagle, Jose Serrano, James E. Knoben and Victor J. Navarro

      Article first published online: 28 FEB 2013 | DOI: 10.1002/hep.26175

    4. You have free access to this content
      The FDA, bridging data, and hepatitis C (pages 875–877)

      Michael W. Fried and Donald M. Jensen

      Article first published online: 28 FEB 2013 | DOI: 10.1002/hep.26177

    5. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study (pages 881–889)

      Norah A. Terrault, Jennifer L. Dodge, Edward L. Murphy, John E. Tavis, Alexi Kiss, T. R. Levin, Robert G. Gish, Michael P. Busch, Arthur L. Reingold and Miriam J. Alter

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26164

    2. You have free access to this content
      IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen–negative patients with chronic hepatitis B (pages 890–896)

      Pietro Lampertico, Mauro Viganò, Cristina Cheroni, Floriana Facchetti, Federica Invernizzi, Vincenza Valveri, Roberta Soffredini, Sergio Abrignani, Raffaele De Francesco and Massimo Colombo

      Article first published online: 20 DEC 2012 | DOI: 10.1002/hep.25749

    3. You have free access to this content
      Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects (pages 897–902)

      Jiang Liu, Pravin R. Jadhav, Shashi Amur, Russell Fleischer, Thomas Hammerstrom, Linda Lewis, Lisa Naeger, Jule O'Rear, Michael Pacanowski, Sarah Robertson, Shirley Seo, Greg Soon and Debra Birnkrant

      Article first published online: 28 DEC 2012 | DOI: 10.1002/hep.25764

    4. You have free access to this content
      Boceprevir dosing for late responders and null responders: The role of bridging data between treatment-naïve and -experienced subjects (pages 903–907)

      Jeffry Florian, Pravin R. Jadhav, Shashi Amur, Ruben Ayala, Patrick Harrington, Poonam Mishra, Jules O'Rear, Michael Pacanowski, Sarah Robertson, Mary Singer, Greg Soon, Wen Zeng and Jeffrey Murray

      Article first published online: 29 JAN 2013 | DOI: 10.1002/hep.25843

    5. You have free access to this content
      Dating the origin and dispersal of hepatitis B virus infection in humans and primates (pages 908–916)

      Dimitrios Paraskevis, Gkikas Magiorkinis, Emmanouil Magiorkinis, Simon Y.W. Ho, Robert Belshaw, Jean-Pierre Allain and Angelos Hatzakis

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26079

    6. You have free access to this content
      Case-control study of hepatitis B and hepatitis C in older adults: Do healthcare exposures contribute to burden of new infections? (pages 917–924)

      Joseph F. Perz, Scott Grytdal, Suzanne Beck, Ana Maria Fireteanu, Tasha Poissant, Elena Rizzo, Katherine Bornschlegel, Ann Thomas, Sharon Balter, Jeremy Miller, R. Monina Klevens and Lyn Finelli

      Article first published online: 7 JAN 2013 | DOI: 10.1002/hep.25688

    7. You have free access to this content
      Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy (pages 925–933)

      Davide Bitetto, Nadia Bortolotti, Edmondo Falleti, Sara Vescovo, Carlo Fabris, Giovanna Fattovich, Annarosa Cussigh, Sara Cmet, Ezio Fornasiere, Elisa Ceriani, Mario Pirisi and Pierluigi Toniutto

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26186

    8. You have free access to this content
      Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion (pages 934–943)

      Hung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, Cheng-Yuan Peng, Chun-Jen Liu, Tai-Chung Tseng, Tung-Hung Su, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen and Jia-Horng Kao

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26121

    9. You have free access to this content
      A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users (pages 944–952)

      Arthur Y. Kim, Ellen H. Nagami, Christopher E. Birch, Melinda J. Bowen, Georg M. Lauer and Barbara H. McGovern

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.26113

    10. You have free access to this content
      Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B (pages 953–963)

      Katharina Esser-Nobis, Inés Romero-Brey, Tom M. Ganten, Jérôme Gouttenoire, Christian Harak, Rahel Klein, Peter Schemmer, Marco Binder, Paul Schnitzler, Darius Moradpour, Ralf Bartenschlager, Stephen J. Polyak, Wolfgang Stremmel, François Penin, Christoph Eisenbach and Volker Lohmann

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26260

    11. You have free access to this content
      Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C (pages 964–973)

      Yasuji Arase, Mariko Kobayashi, Fumitaka Suzuki, Yoshiyuki Suzuki, Yusuke Kawamura, Norio Akuta, Masahiro Kobayashi, Hitomi Sezaki, Satoshi Saito, Tetsuya Hosaka, Kenji Ikeda, Hiromitsu Kumada and Tetsuro Kobayashi

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26087

    12. You have free access to this content
      Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial (pages 974–984)

      Mark S. Sulkowski, Fred Poordad, Michael P. Manns, Jean-Pierre Bronowicki, K. Rajender Reddy, Stephen A. Harrison, Nezam H. Afdhal, Heather L. Sings, Lisa D. Pedicone, Kenneth J. Koury, Vilma Sniukiene, Margaret H. Burroughs, Janice K. Albrecht, Clifford A. Brass, Ira M. Jacobson and for the SPRINT-2 Trial Investigators

      Article first published online: 11 FEB 2013 | DOI: 10.1002/hep.26096

    13. You have free access to this content
  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Aging promotes the development of diet-induced murine steatohepatitis but not steatosis (pages 995–1004)

      Luis Fontana, Enpeng Zhao, Muhammad Amir, Hanqing Dong, Kathryn Tanaka and Mark J. Czaja

      Article first published online: 12 FEB 2013 | DOI: 10.1002/hep.26099

    2. You have free access to this content
      The role of CCAAT enhancer-binding protein homologous protein in human immunodeficiency virus protease-inhibitor–induced hepatic lipotoxicity in mice (pages 1005–1016)

      Yun Wang, Luyong Zhang, Xudong Wu, Emily C. Gurley, Elaine Kennedy, Phillip B. Hylemon, William M. Pandak, Arun J. Sanyal and Huiping Zhou

      Article first published online: 12 FEB 2013 | DOI: 10.1002/hep.26107

    3. You have free access to this content
      Placental stem cell correction of murine intermediate maple syrup urine disease (pages 1017–1023)

      Kristen J. Skvorak, Kenneth Dorko, Fabio Marongiu, Veysel Tahan, Marc C. Hansel, Roberto Gramignoli, K. Michael Gibson and Stephen C. Strom

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.26150

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma (pages 1024–1034)

      Qiong-Zhu Dong, Xiao-Fei Zhang, Yue Zhao, Hu-Liang Jia, Hai-Jun Zhou, Chun Dai, Hai-Jing Sun, Yi Qin, Wei-De Zhang, Ning Ren, Qing-Hai Ye and Lun-Xiu Qin

      Article first published online: 11 FEB 2013 | DOI: 10.1002/hep.26103

    2. You have free access to this content
      Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma (pages 1035–1045)

      Mona El Khatib, Anna Kalnytska, Vindhya Palagani, Uta Kossatz, Michael P. Manns, Nisar P. Malek, Ludwig Wilkens and Ruben R. Plentz

      Article first published online: 25 JAN 2013 | DOI: 10.1002/hep.26147

      Corrected by:

      Corrections: Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases tumor necrosis of cholangiocellular carcinomas

      Vol. 60, Issue 2, 771, Article first published online: 22 JUL 2014

    3. You have free access to this content
      Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma (pages 1046–1054)

      Calogero Cammà, Giuseppe Cabibbo, Salvatore Petta, Marco Enea, Massimo Iavarone, Antonio Grieco, Antonio Gasbarrini, Erica Villa, Claudio Zavaglia, Raffaele Bruno, Massimo Colombo, Antonio Craxì and on behalf of the WEF and the SOFIA study groups

      Article first published online: 12 FEB 2013 | DOI: 10.1002/hep.26221

    4. You have free access to this content
      Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b (pages 1055–1067)

      Jeong Kyu Kim, Ji Heon Noh, Kwang Hwa Jung, Jung Woo Eun, Hyun Jin Bae, Min Gyu Kim, Young Gyoon Chang, Qingyu Shen, Won Sang Park, Jung Young Lee, Jürgen Borlak and Suk Woo Nam

      Article first published online: 11 FEB 2013 | DOI: 10.1002/hep.26101

    5. You have free access to this content
    6. You have free access to this content
      Prognostic factors and prevention of radioembolization-induced liver disease (pages 1078–1087)

      Belen Gil-Alzugaray, Ana Chopitea, Mercedes Iñarrairaegui, Jose I. Bilbao, Macarena Rodriguez-Fraile, Javier Rodriguez, Alberto Benito, Inés Dominguez, Delia D'Avola, Jose I. Herrero, Jorge Quiroga, Jesus Prieto and Bruno Sangro

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.26191

    7. You have free access to this content
      Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1–dependent apoptotic pathway (pages 1088–1097)

      Hai-Xiang Sun, Yang Xu, Xin-Rong Yang, Wei-Min Wang, Haibo Bai, Ruo-Yu Shi, Suresh K. Nayar, Ranjan P. Devbhandari, Yi-zhou He, Qin-Feng Zhu, Yun-Fan Sun, Bo Hu, Mehtab Khan, Robert A. Anders and Jia Fan

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26188

    8. You have free access to this content
      Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer (pages 1098–1106)

      Yanjun Jiang, Polina Iakova, Jingling Jin, Emily Sullivan, Vladislav Sharin, Il-Hwa Hong, Sayee Anakk, Angela Mayor, Gretchen Darlington, Milton Finegold, David Moore and Nikolai A. Timchenko

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.26146

    9. You have free access to this content
      Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions (pages 1107–1116)

      Yan Wu, Dong-Ming Kuang, Wei-Dong Pan, Yun-Le Wan, Xiang-Ming Lao, Dian Wang, Xue-Feng Li and Limin Zheng

      Article first published online: 18 JAN 2013 | DOI: 10.1002/hep.26192

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      α5β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes (pages 1117–1129)

      Holger Gohlke, Birte Schmitz, Annika Sommerfeld, Roland Reinehr and Dieter Häussinger

      Article first published online: 17 SEP 2012 | DOI: 10.1002/hep.25992

    2. You have free access to this content
      Modulation of the biliary expression of arylalkylamine N-acetyltransferase alters the autocrine proliferative responses of cholangiocytes in rats (pages 1130–1141)

      Anastasia Renzi, Sharon DeMorrow, Paolo Onori, Guido Carpino, Romina Mancinelli, Fanyin Meng, Julie Venter, Mellanie White, Antonio Franchitto, Heather Francis, Yuyan Han, Yoshiyuki Ueno, Giuseppina Dusio, Kendal J. Jensen, John J. Greene Jr., Shannon Glaser, Eugenio Gaudio and Gianfranco Alpini

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26105

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Circulating neutrophil dysfunction in acute liver failure (pages 1142–1152)

      Nicholas J. Taylor, Anirudh Nishtala, Godhev K. Manakkat Vijay, R. Daniel Abeles, Georg Auzinger, William Bernal, Yun Ma, Julia A. Wendon and Debbie L. Shawcross

      Article first published online: 12 DEC 2012 | DOI: 10.1002/hep.26102

    2. You have free access to this content
      Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial (pages 1153–1162)

      Rafael Bañares, Frederik Nevens, Fin Stolze Larsen, Rajiv Jalan, Agustín Albillos, Matthias Dollinger, Faouzi Saliba, Tilman Sauerbruch, Sebastian Klammt, Johann Ockenga, Albert Pares, Julia Wendon, Tanja Brünnler, Ludwig Kramer, Philippe Mathurin, Manuel de la Mata, Antonio Gasbarrini, Beat Müllhaupt, Alexander Wilmer, Wim Laleman, Martin Eefsen, Sambit Sen, Alexander Zipprich, Teresa Tenorio, Marco Pavesi, Hartmut H.-J. Schmidt, Steffen Mitzner, Roger Williams, Vicente Arroyo and on behalf of the RELIEF study group

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.26185

    3. You have free access to this content
      Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis (pages 1163–1171)

      Loïc Rolas, Nesrine Makhezer, Soumeya Hadjoudj, Jamel El-Benna, Bahia Djerdjouri, Laure Elkrief, Richard Moreau and Axel Périanin

      Article first published online: 4 FEB 2013 | DOI: 10.1002/hep.26109

    4. You have free access to this content
      Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction (pages 1172–1181)

      Vincenzo La Mura, Marcos Pasarín, Cintia Z. Meireles, Rosa Miquel, Aina Rodríguez-Vilarrupla, Diana Hide, Jorge Gracia-Sancho, Juan Carlos García-Pagán, Jaime Bosch and Juan G. Abraldes

      Article first published online: 25 JAN 2013 | DOI: 10.1002/hep.26127

  8. Liver Injury/Regeneration

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Determination of reliability criteria for liver stiffness evaluation by transient elastography (pages 1182–1191)

      Jérôme Boursier, Jean-Pierre Zarski, Victor de Ledinghen, Marie-Christine Rousselet, Nathalie Sturm, Brigitte Lebail, Isabelle Fouchard-Hubert, Yves Gallois, Frédéric Oberti, Sandrine Bertrais, Paul Calès and the Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies

      Article first published online: 4 FEB 2013 | DOI: 10.1002/hep.25993

    2. You have free access to this content
      Differentiation capacity of hepatic stem/progenitor cells isolated from D-galactosamine-treated rat livers (pages 1192–1202)

      Norihisa Ichinohe, Naoki Tanimizu, Hidekazu Ooe, Yukio Nakamura, Toru Mizuguchi, Junko Kon, Koichi Hirata and Toshihiro Mitaka

      Article first published online: 27 JAN 2013 | DOI: 10.1002/hep.26084

    3. You have free access to this content
      β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury (pages 1203–1214)

      Bibo Ke, Xiu-Da Shen, Naoko Kamo, Haofeng Ji, Shi Yue, Feng Gao, Ronald W. Busuttil and Jerzy W. Kupiec-Weglinski

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.26100

    4. You have free access to this content
    5. You have free access to this content
      Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: Immunomodulation by the cAMP-PKA pathway (pages 1225–1237)

      Haofeng Ji, Yu Zhang, Xiu-da Shen, Feng Gao, Cynthia Y. Huang, Catalina Abad, Ronald W. Busuttil, James A. Waschek and Jerzy W. Kupiec-Weglinski

      Article first published online: 18 JAN 2013 | DOI: 10.1002/hep.25802

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have full text access to this OnlineOpen article
      Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor–induced TIMP-1 gene transcription in hepatic stellate cells in mice (pages 1238–1249)

      Maria J. Perugorria, Lindsay B. Murphy, Nicola Fullard, Jayashree B. Chakraborty, Dimitra Vyrla, Caroline L. Wilson, Fiona Oakley, Jelena Mann and Derek A. Mann

      Article first published online: 28 FEB 2013 | DOI: 10.1002/hep.26108

    2. You have free access to this content
      Intestinal mucus-derived nanoparticle–mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice (pages 1250–1261)

      Zhong-Bin Deng, Xiaoying Zhuang, Songwen Ju, Xiaoyu Xiang, Jingyao Mu, Qilong Wang, Hong Jiang, Lifeng Zhang, Mitchell Kronenberg, Jun Yan, Donald Miller and Huang-Ge Zhang

      Article first published online: 11 FEB 2013 | DOI: 10.1002/hep.26086

  10. Review

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
  11. Hepatology Elsewhere

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Spleen stiffness: Toward a noninvasive portal sphygmomanometer? (pages 1278–1280)

      Juan G. Abraldes, Enric Reverter and Annalisa Berzigotti

      Article first published online: 12 FEB 2013 | DOI: 10.1002/hep.26239

  12. Clinical Observations in Hepatology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Use of a xanthine oxidase inhibitor in autoimmune hepatitis (pages 1281–1282)

      Safa Al-Shamma, Balint Eross and Simon Mclaughlin

      Article first published online: 4 FEB 2013 | DOI: 10.1002/hep.26198

  13. Correspondence

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Review
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Reply (pages 1283–1284)

      Pietro Lampertico, Enrico Galmozzi and Massimo Colombo

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.25882

    3. You have free access to this content
      Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis (page 1284)

      Jannis Kountouras, Christos Zavos, Georgia Deretzi, Elizabeth Vardaka, Marina Boziki, Emmanouel Gavalas, George Kouklakis, Panagiotis Katsinelos, Ioannis Venizelos, Christina Nikolaidou, Stergios A. Polyzos and Evaggelia Giartza-Taxidou

      Article first published online: 4 FEB 2013 | DOI: 10.1002/hep.25926

    4. You have free access to this content
      Cognitive dysfunction, falls and helicobacter pylori in cirrhosis (page 1285)

      German Soriano, Eva Román and Joan Córdoba

      Article first published online: 4 FEB 2013 | DOI: 10.1002/hep.25922

    5. You have free access to this content
      Disparate profiles of dys-regulated miRNAs in activated hepatic stellate cells (pages 1285–1286)

      Shao-Long Chen, Ming-Hua Zheng, Tao Yang, Mei Song and Yong-Ping Chen

      Article first published online: 7 FEB 2013 | DOI: 10.1002/hep.25975

    6. You have free access to this content
      Reply (pages 1286–1287)

      Ashley M. Lakner, Nury M. Steuerwald and Laura W. Schrum

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.25997

    7. You have free access to this content
    8. You have free access to this content
      Reply (pages 1287–1288)

      Da-Qiang Li and Rakesh Kumar

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.25973

    9. You have free access to this content
      A new feature of the MYH9-related syndrome: Chronic transaminase elevation (pages 1288–1289)

      Rémi Favier, Analisa DiFeo, Nathalie Hezard, Monique Fabre, Pierre Bedossa and John A. Martignetti

      Article first published online: 27 NOV 2012 | DOI: 10.1002/hep.25913

SEARCH

SEARCH BY CITATION